General


Peptide: 1018 or IDR-1018
Microorganism:Pseudomonas aeruginosa
Administration:
Stage: Formation (3-24h)
Notes:

Experimental procedure


Method AMP Effect(Biofilm reduction) Concentration Notes
Crystal violet assay 21 - 50% 6.51 uM 7 clinical isolate of 13 strains
Crystal violet assay 51 - 90% 6.51 uM 5 clinical isolates of 13 strains
Crystal violet assay <= 20 % 6.51 uM 1 clinical isolate of 13 strains

Reference



M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.

Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com